Forums » Immunology

List of newest posts

    • April 7, 2021 12:55 PM BST
    • Based on real examples, reflect on the challenges encountered and solutions developed to detect NAb for immunogenicity assessment with Dr.Regina Bruyns and Sripriya Jaganathan on April 20 at 4pm CET.

      In this 45-minute interactive event, we will address the following points:
      • Neutralizing anti-drug antibodies
      • Competitive ligand binding assay formats to detect NAb
      • Challenges in NAb detection
      • Approaches to minimize drug interference in NAb assays
      • Live Q & A session

      Join us, it's 100% FREE.

      REGISTER HERE: https://zoom.us/webinar/register/2916177964737/WN__ae_VvMPT0yxvuMtOZNhvQ

    • December 4, 2018 11:16 PM GMT
    • This is going to be just the information anybody around the world needs to know.

      We need long life expectancy irrespective of what's happening around us.

      Good job

       

    • December 4, 2018 11:11 AM GMT
    • Amgen Oncology is leading the development of novel therapies that specifically harness the body’s T cells, pioneering the first immuno-oncology program using a BiTE®, or bispecific T cell engager. Explore the world of BiTE® immunotherapy as Amgen scientists Dr. Dirk Nagorsen and Dr. Peter Kufer discuss the current cancer treatment landscape, explain how BiTE® works and offer a preview of how Amgen is bringing this technology into the future of cancer treatment.

    • November 28, 2018 5:10 PM GMT
    • Ulcerative colitis is a common form of inflammatory bowel disease. For many people with the condition, widely prescribed anti-inflammatory or immunosuppressive drugs do not remain effective for long, and up to 15% of patients will need surgery to remove all or part of the colon within 20 years of diagnosis. This animation explores how insights into the immunobiology of ulcerative colitis are helping researchers to develop innovative treatments.

      Read some in-depth articles on ulcerative colitis at https://www.nature.com/collections/qwtdpjcrpg

    • November 5, 2018 6:18 PM GMT
    • Our immune systems are at war with cancer. This animation by nature video reveals how monoclonal antibodies can act as valuable reinforcements to shore up our defences – and help battle cancer.
      You can find more on this topic at:
      http://www.nature.com/milestones/mileantibodies/index.html


    • March 13, 2018 6:33 PM GMT
    • This 1.5-day seminar will cover the fundamentals of human immunology for an audience of scientists across different backgrounds working in pharmaceutical and biotech organizations in programs related to immuno-therapy. The course will cover a historical perspective, basic mechanisms, fundamental concepts and practical approaches to developing therapeutics and their combinations to modulate the immune system. Additionally, the class will offer perspectives on how immune responses can be monitored by assessment of biomarkers and modulated through biopharmaceutical intervention. Through group activities, attendees will actively review immunological concepts as well as design functional immunological assays and read-outs.

      http://www.pegsummit.com/PEGS_Training_Seminar_Immunology/